Literature DB >> 23681020

Validation of an adapted arabic version of fibromyalgia syndrome impact questionnaire.

Mai Abd El-Naby1, Mohamed Ahmed Hefny, Ayman Ekram Fahim, Magdy Ahmed Awadalla.   

Abstract

Fibromyalgia (FM) is the most common chronic pain syndrome encountered in medical practice, affecting females more than males, and the estimated prevalence of FM in Egypt is 1.3 %. The aim was to translate and adapt the Fibromyalgia Impact Questionnaire (FIQ) into Arabic and assess reliability and validity. The Arabic version of Fibromyalgia Impact Questionnaire (FIQ-A) was adapted following the forward/backward translation approach. Fifty-one female patients with FM were studied to assess psychometric properties of the FIQ-A. Reliability was analyzed by the correlation coefficient between test and retest. Internal consistency was checked by the Cronbach's alpha coefficient. Construct validity was assessed comparing FIQ-A with Health Assessment Questionnaire (HAQ), Health Assessment Questionnaire of Fibromyalgia (FHAQ), The Medical Outcome Survey Short-Form-36 (SF-36), and the Total Visual Analog Scale (TVAS) for FM symptom, and feasibility was assessed by the time taken in completing the FIQ-A and the proportion of patients completed the questionnaire. Patients studied were 33.2 ± 9.8 years old. Translation was concordant. Adaptation affected 4 sub-items of physical function. Test-retest correlation coefficient was 0.89 for total FIQ-A and Cronbach's alpha was 0.76. Excellent to good statistically significant correlations (p < 0.05) were found between the FIQ-A items and HAQ, FHAQ, and SF-36. The FIQ-A is a reliable, valid for measuring health status and physical function in Arabic-speaking FM patients.

Entities:  

Mesh:

Year:  2013        PMID: 23681020     DOI: 10.1007/s00296-013-2779-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

Authors:  R Bennett
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

3.  Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G).

Authors:  M Offenbaecher; M Waltz; P Schoeps
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

4.  The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire.

Authors:  F Wolfe; D J Hawley; D L Goldenberg; I J Russell; D Buskila; L Neumann
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

5.  Development of the Japanese version of the Fibromyalgia Impact Questionnaire (JFIQ): psychometric assessments of reliability and validity.

Authors:  Kenichi Osada; Hiroshi Oka; Tatsuya Isomura; Ikuro Nakamura; Keiichiro Tominaga; Shinobu Takahashi; Ayako Kojima; Kusuki Nishioka
Journal:  Int J Rheum Dis       Date:  2011-02       Impact factor: 2.454

6.  Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians.

Authors:  Reem Hamdy Abdellatif Mohammed; Hesham Ibrahim ElMakhzangy; Amira Gamal; Fatma Mekky; Mohammed El Kassas; Nabil Mohammed; Mohammed Abdel Hamid; Gamal Esmat
Journal:  Clin Rheumatol       Date:  2010-04-22       Impact factor: 2.980

7.  The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia.

Authors:  J Rivera; T González
Journal:  Clin Exp Rheumatol       Date:  2004 Sep-Oct       Impact factor: 4.473

8.  A randomized, controlled clinical trial of education and physical training for women with fibromyalgia.

Authors:  C S Burckhardt; K Mannerkorpi; L Hedenberg; A Bjelle
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

Review 9.  Chronic widespread pain and fibromyalgia: what we know, and what we need to know.

Authors:  Daniel J Clauw; Leslie J Crofford
Journal:  Best Pract Res Clin Rheumatol       Date:  2003-08       Impact factor: 4.098

10.  The fibromyalgia impact questionnaire: development and validation.

Authors:  C S Burckhardt; S R Clark; R M Bennett
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666

View more
  5 in total

Review 1.  Rheumatology in Egypt: back to the future.

Authors:  Tamer A Gheita; Nahla N Eesa
Journal:  Rheumatol Int       Date:  2018-11-07       Impact factor: 2.631

2.  Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis.

Authors:  Nada Mahmoud Shresher; Aly Elsayed Mohamed; Mohsen Hassan Elshahaly
Journal:  Rheumatol Int       Date:  2019-08-03       Impact factor: 2.631

3.  Validation of a Persian version of the Fibromyalgia Impact Questionnaire (FIQ-P).

Authors:  Ali Bidari; Morteza Hassanzadeh; Mohamad-Farzam Mohabat; Elham Talachian; Effat Merghati Khoei
Journal:  Rheumatol Int       Date:  2013-10-29       Impact factor: 2.631

4.  Evaluating Gender Differences in Egyptian Fibromyalgia Patients Using the 1990, 2011, and 2016 ACR Criteria.

Authors:  Abdelhfeez Moshrif; Mohamed Z Shoaeir; Awad Saad Abbas; Tarek M Abdel-Aziz; Wesam Gouda
Journal:  Open Access Rheumatol       Date:  2022-04-23

5.  Comorbidity of Fibromyalgia in Primary Knee Osteoarthritis: Potential Impact on Functional Status and Quality of Life.

Authors:  Marwa Yahia Mahgoub; Basant Mohamed Elnady; Haytham Sayed Abdelkader; Raghdaa Abdelkhaleq Abdelhalem; Waleed Ahmed Hassan
Journal:  Open Access Rheumatol       Date:  2020-05-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.